Subject: RE: Expression of interest – voluntary surveillance Hepatitis E
From: "FWD ECDC" <[email-masked]>
To: "Sabine Maritschnik" <[email-masked]>, "Christian Kornschober" <[email-masked]>, "Dieter Van Cauteren" <[email-masked]>, "Geraldine De Muylder" <[email-masked]>, "Borislava Tsafarova" <[email-masked]>, "Ivelina Zhivkova" <[email-masked]>, "Petya Stefanova" <[email-masked]>, "Iva Pem Novosel" <[email-masked]>,Sanja Kurečić-Filipović <[email-masked]>, "Aristos Aristodemou" <[email-masked]>, "Maria Meropi Charalambous" <[email-masked]>,Ondřej Daniel <ondrej.danie
Cc: "Austria Generic Email Box -" <[email-masked]>, "Sigrid Kiermayr" <[email-masked]>, "Koen Blot" <[email-masked]>, "Belgium Generic Email Box - Coordinating Competent Body" <[email-masked]>, "Julien Sohier" <[email-masked]>, "Zhivka Getsova" <[email-masked]>, "Iva Christova" <[email-masked]>, "Krunoslav Capak" <[email-masked]>, "Bernard Kaic" <[email-masked]>,Ivan Mlinarić <[email-masked]>, "Elisavet Constantinou" <[email-masked]>, <[email-masked]>, <[email-masked]>,Kamilla Grønborg
Date: Tue, 25 Nov 2025 12:11:29 +0200

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.

To:  National Focal Points for FWD, OCPs Microbiology and Epidemiology for 
Hepatitis A

CC: National Coordinators

Dear Colleagues,

Thank you to all who have already responded to the below email regarding the 
initiative to set up voluntary Hepatitis E surveillance at the EU/EEA level.

We are pleased to share that so far 10 countries have expressed interest in 
collaborating on this effort.

For those who have not yet had the opportunity to respond, we warmly 
encourage you to do so at your earliest convenience. Your input will help us 
better understand the overall level of interest and ensure that the proposal 
reflects the needs and priorities across Member States.

For those who have expressed interest, we will follow-up next year with 
further details and next steps on this topic.

Thank you once again for your engagement and support in strengthening 
disease surveillance at the EU/EEA level.

On behalf of the FOVEZ team at ECDC,

Best regards,

Liese Van Gompel

From: FWD ECDC
Sent: 17 November 2025 17:03
To: [email-masked]; Christian.Kornschober 
<[email-masked]>; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; Mathieu TOURDJMAN 
<[email-masked]>; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; Gaia 
Scavia <[email-masked]>; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; Lavinia Rusu 
<[email-masked]>; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
Helen Byrne <[email-masked]>; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; Luise Müller 
<[email-masked]>; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]
Cc: [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; Nerija Kupreviciene 
<[email-masked]>; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; [email-masked]; 
[email-masked]; [email-masked]; 
[email-masked]; 
[email-masked]; 
[email-masked]; 
[email-masked]
Subject: Expression of interest – voluntary surveillance Hepatitis E

To:  National Focal Points for FWD, OCPs Microbiology and Epidemiology for 
Hepatitis A

Copy: National Coordinators

Dear Colleagues,

I hope this email finds you well.

Following feedback we have received from several Member States in the past 
years, ECDC is exploring setting up voluntary data collection for Hepatitis 
E surveillance at the EU/EEA level.

We are currently working on a proposal outlining surveillance objectives, 
case definitions, and variables to be collected. This proposal will further 
build on the Hepatitis E guidance developed in 2019 by the ECDC HEV expert 
group consisting of country nominated experts and scientists working on HEV 
relevant fields, and will largely reflect the decisions made during this 
consultation process 
(https://www.ecdc.europa.eu/sites/default/files/documents/hepatitis-e-guidance.pdf). 
The final proposal will be discussed in the coming months with countries 
interested in participating.

To help us plan, we would be grateful if you could let us know by next week 
Monday 24 November:

- If you would be interested in reviewing the proposal;

- If you would be interested in submitting data starting next year (timeline 
to be confirmed);

- Who would be the contact person(s) for your country?

We aim to keep data collection practical and focused, avoiding unnecessary 
details while ensuring a meaningful first step toward coordinated 
surveillance.

Thank you very much for your consideration, and we look forward to your 
response.

For your information, in parallel, the ONWARD (One Health Zoonotic Hepevirus 
Network) project was launched in September 2025 under the European 
Cooperation in Science and Technology (COST) framework (Action 
<https://www.cost.eu/actions/CA24140/>  CA24140 - COST), offering ECDC also 
an opportunity for collaboration while we are setting up the voluntary 
surveillance; please note that this initiative is independent and not 
managed by ECDC.

Looking forward hearing from you,

On behalf of the FOVEZ team at ECDC,

Best regards,

Liese Van Gompel

Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly 
requested, to, consecutively, refrain from disclosing its content to any 
third party, delete it and inform its sender of the erroneous transmittal.

Classified as ECDC NORMAL